Physician profile
Millie A Behera
NPI 1912932559
$14,546.61
in general payments reported to CMS, 2019-2025
18 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,480 · 2020: $1,064 · 2021: $3,031 · 2022: $1,137 · 2023: $454 · 2024: $53.16 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,941.41 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $4,309.87 | 2019 | |
| Pfizer INC. | $2,960.00 | 2021 | |
| Coopersurgical, INC. | $568.59 | 2021-2023 | Stripper |
| Emd Serono, INC. | $342.91 | 2019-2023 | |
| Minerva Surgical, INC | $340.83 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $307.53 | 2019-2025 | Menopur |
| Hologic Sales and Service, LLC | $244.03 | 2022-2025 | Magtrace, Myosure Tissue Removal Device, Aptima |
| Becton, Dickinson and Company | $129.83 | 2025 | Bd Onclarity |
| Alexion Pharmaceuticals, INC. | $106.32 | 2019 | |
| Roche Diagnostics Corporation | $106.08 | 2023 | Cobas 4800 Ct/Ng Test V2.0 |
| Viiv Healthcare Company | $105.44 | 2023 | Apretude |
| Organon LLC | $21.74 | 2024 | |
| Boston Scientific Corporation | $17.17 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.14 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $15.08 | 2023 | Guardia |
| Covidien LP | $13.64 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Millie Behera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.